Cells that are supposed to die sometimes remain in the body for years, damaging tissues. Researchers are now looking for a way to clear them out.
As we age, damaged cells accumulate in the body that, instead of dying, remain in tissues and damage organs by secreting inflammatory substances. Scientists call these cells "zombie cells" and believe that their accumulation may play a role in the onset of aging-related diseases, including heart problems and dementia. Recent research shows that it might be possible to reduce some of the consequences of aging by enhancing the immune system's ability to clear these cells.
According to TahaSite, citing Live Science, researchers have explored various methods in recent years to destroy senescent cells. One of these methods is the use of drugs called "senolytics," which force damaged cells to undergo programmed cell death. Animal experiments have shown that such drugs can reduce inflammation and improve the function of certain tissues. However, a group of scientists is pursuing a different solution: restoring the immune system's natural ability to eliminate senescent cells.
Why do zombie cells accumulate in the body?
The human body constantly identifies and eliminates worn-out and dead cells. An important part of this process is handled by immune cells known as "macrophages." By identifying chemical signals on the surface of dying cells, these cells engulf and break them down.
However, not all damaged cells are destroyed. Due to factors such as DNA damage, oxidative stress, or repeated divisions, some of them lose their ability to replicate and enter a state known as "cellular senescence."
Zombie cells, or senescent cells, no longer divide, but instead of dying and being cleared from the body, they can damage surrounding tissues by secreting inflammatory substances.
Cellular senescence is not always harmful and plays a role, for example, in wound healing. The problem begins when these cells remain in tissues for a long time. Under such conditions, they secrete inflammatory chemicals that can damage healthy surrounding cells and impair organ function.
Roel De Maeyer, an immunologist at the University of Oxford, explains that the accumulation of a large number of senescent cells in a tissue is usually an unfavorable sign. According to him, rejuvenating the immune system might help resolve many of the problems associated with aging.
Discovery of a Receptor That Impairs Immune Cell Function
One of the important findings of recent research relates to a receptor called EP2, which is located on the surface of macrophages. A study published in July in the journal Science showed that as age increases, the number of these receptors on macrophages increases, and their ability to clear senescent cells decreases.
To investigate the role of this receptor, researchers genetically knocked it out in laboratory mice. The results showed that macrophages regained their ability to effectively eliminate senescent cells.
Compared to normal mice of the same age, the engineered mice showed less inflammation, and the signs of muscle wasting, cardiac dysfunction, and cognitive decline were milder in them. Even their memory performance in certain tests, such as recognizing familiar objects, was similar to that of younger mice.
Researchers believe these results can help explain the connection between immune system aging and the functional decline of various organs.
Senescent Immune Cells Lack Sufficient Energy for Clearance
A group of researchers at Stanford University, led by Katrin Andreasson, had previously found in 2021 that increased activity of the EP2 receptor alters how macrophages consume energy.
Young macrophages burn glucose to perform their tasks and generate energy. However, with increased EP2 activity, these cells store glucose instead of consuming it, and as a result, they lack the energy required to engulf worn-out cells.
Andreasson explains that engulfing cells is a very energy-intensive process. Therefore, a disruption in macrophage metabolism can severely reduce their clearance capacity.
As age increases, the immune system's ability to clear senescent cells decreases, setting the stage for the accumulation of zombie cells.
The EP2 receptor is activated under the influence of an inflammatory molecule called PGE2. This molecule belongs to the prostaglandin family, which plays a role in pain, fever, and inflammation. Drugs like ibuprofen also help reduce inflammation by inhibiting prostaglandin production.
The connection between this biological pathway and age-related diseases has long captured the attention of scientists. For example, a 2001 study showed that individuals over 55 who had regularly used prostaglandin inhibitor drugs for at least two years were less likely to develop Alzheimer's disease. Of course, this association did not prove a preventive effect of the drugs.
Subsequent research demonstrated that inhibiting EP2 can restore normal energy consumption in macrophages and is associated with reduced inflammation and improved cognitive function in aged mice.
How Do Zombie Cells Escape Destruction?
The weakness of macrophages is not the only reason senescent cells accumulate. Some of these cells use defense mechanisms to hide from the immune system.
One such mechanism involves a protein called CD47. This protein exists on the surface of living cells and transmits a "don't eat me" signal to macrophages so that healthy cells are not mistakenly destroyed.
However, researchers at the Max Planck Institute discovered in a 2023 study that this signal is amplified in senescent cells. The contact of macrophages with such cells can disrupt their function—to the extent that they even lose the ability to clear normal dead cells.
Zombie cells prevent macrophages from destroying them by amplifying the molecular "don't eat me" signal, and they even impair their ability to clear other dead cells.
Jure Poysein, a biochemist at the Max Planck Institute, says that weakening this message could be a way to help the immune system. However, because CD47 is also present on healthy cells, its broad inhibition could become problematic.
Instead, researchers have identified an enzyme that alters the CD47 protein in senescent cells. Experiments have shown that inhibiting this enzyme can prevent macrophage dysfunction and potentially offer a more selective way to target zombie cells.
Furthermore, the new study by Andriasson's group showed that in aged mice, a type of immune cell called neutrophils also enters a state of cellular senescence and accumulates in tissues. Neutrophils typically live for only a few days, but macrophage dysfunction prevents their proper clearance. Because these cells can induce severe inflammation, their accumulation may lead to more widespread tissue damage.
Can these findings be used for human rejuvenation?
Despite the promising results from animal experiments, translating these findings into a safe and effective treatment for humans still faces numerous obstacles.
Laboratory mice are usually genetically very similar and live in controlled environmental conditions. In contrast, genetic differences, lifestyles, and environmental factors in humans can alter treatment outcomes.
EP2 inhibitor drugs have so far been mostly investigated in the context of cancer treatment, and limited information exists regarding their long-term effects on human aging. Methods based on CD47 targeting are also still in the early stages of research.
Although enhancing the immune system's clearance ability in mice has shown promising results, the safety and efficacy of this method in slowing down the aging process in humans have not yet been proven.
Previous efforts to rejuvenate macrophages have also faced limitations. For example, in 2020, De Meyer's research group tested an experimental drug called losmapimod on individuals aged 65 and older. By inhibiting a protein called p38, this drug managed to improve the function of certain immune cells, but the occurrence of liver problems in subsequent trials made its long-term use unsuitable.
Andriasson says that EP2 inhibition in her group's experiments on mice has not been associated with obvious side effects, but human studies must be conducted to ensure the safety and efficacy of this method.
The goal of these researches is not to completely stop aging, but to reduce the damage caused by the accumulation of senescent cells and to increase the years of life that individuals spend free from age-related diseases and disabilities. For now, none of these methods have been approved as an anti-aging treatment for humans, and the results of animal studies are not sufficient to recommend drug consumption.
Comments